Uta D.
- Country
- Germany
- Department
- Zentrum für Kinder- und Jugendmedizin Klinik für Kinderheilkunde III
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Safety and Efficacy of Asciminib, Blinatumomab, and Combination Therapy in Pediatric and Young Adult Patients with Relapsed/Refractory BCR::ABL1+ or Ph-like ALL
- Asciminib in Pediatric Philadelphia-Positive Chronic Myeloid Leukemia in Chronic Phase With or Without T315I Mutation: Phase II Safety and Efficacy Study
Data & Insights
Has run more than one trial at 107 of 243 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating pediatric and adolescent cancers, with particular emphasis on developing innovative therapeutic approaches for challenging cases.
- Ewing Sarcoma Management
- Acute Lymphoblastic Leukemia Treatment
- Solid Tumor Therapies
Their work encompasses both standard-risk and high-risk disease presentations, focusing on integrating novel therapeutic agents with established treatment protocols.
Targeted Therapies
The investigator focuses on developing and implementing targeted therapeutic approaches for various pediatric malignancies.
- Immunotherapy Applications
- Combination Treatment Strategies
- Maintenance Therapy Protocols
Their expertise includes evaluating novel drug combinations and investigating targeted agents for specific molecular markers in pediatric cancers.
Refractory Disease
The investigator has significant experience in treating refractory and relapsed cancers in young patients, developing strategies for challenging cases.
- Advanced Sarcoma Treatment
- Resistant Disease Management
- Novel Treatment Combinations
Their work includes evaluating innovative approaches for patients who have not responded to conventional treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.